337 related articles for article (PubMed ID: 19062001)
21. Pregnancy outcome in patients with stage 1a endometrial adenocarcinoma, who conservatively treated with megestrol acetate.
Shirali E; Yarandi F; Eftekhar Z; Shojaei H; Khazaeipour Z
Arch Gynecol Obstet; 2012 Mar; 285(3):791-5. PubMed ID: 21805142
[TBL] [Abstract][Full Text] [Related]
22. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
Ramirez PT; Frumovitz M; Bodurka DC; Sun CC; Levenback C
Gynecol Oncol; 2004 Oct; 95(1):133-8. PubMed ID: 15385122
[TBL] [Abstract][Full Text] [Related]
23. [Hormonal therapy and chemotherapy of endometrial cancer].
Krauss T; Huschmand H; Hinney B; Viereck V; Emons G
Zentralbl Gynakol; 2002 Jan; 124(1):45-50. PubMed ID: 11873314
[TBL] [Abstract][Full Text] [Related]
24. Outcome of in vitro fertilization treatment in infertile women conservatively treated for endometrial adenocarcinoma.
Elizur SE; Beiner ME; Korach J; Weiser A; Ben-Baruch G; Dor J
Fertil Steril; 2007 Dec; 88(6):1562-7. PubMed ID: 17412340
[TBL] [Abstract][Full Text] [Related]
25. Long-term conservative therapy for endometrial adenocarcinoma in young women.
Yahata T; Fujita K; Aoki Y; Tanaka K
Hum Reprod; 2006 Apr; 21(4):1070-5. PubMed ID: 16361282
[TBL] [Abstract][Full Text] [Related]
26. Fertility-sparing therapy for young women with endometrial cancer.
Frumovitz M; Gershenson DM
Expert Rev Anticancer Ther; 2006 Jan; 6(1):27-32. PubMed ID: 16375641
[TBL] [Abstract][Full Text] [Related]
27. Advanced endometrial cancer detected at 7 months after childbirth.
Kodama J; Yoshinouchi M; Miyagi Y; Kobashi Y; Kamimura S; Okuda H; Kudo T
Gynecol Oncol; 1997 Mar; 64(3):501-6. PubMed ID: 9062160
[TBL] [Abstract][Full Text] [Related]
28. Hysteroscopic resection in the management of early-stage endometrial cancer: report of 2 cases and review of the literature.
Arendas K; Aldossary M; Cipolla A; Leader A; Leyland NA
J Minim Invasive Gynecol; 2015 Jan; 22(1):34-9. PubMed ID: 25196160
[TBL] [Abstract][Full Text] [Related]
29. Hysteroscopic surgery does not adversely affect the long-term prognosis of women with endometrial adenocarcinoma.
Vilos GA; Edris F; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
J Minim Invasive Gynecol; 2007; 14(2):205-10. PubMed ID: 17368258
[TBL] [Abstract][Full Text] [Related]
30. Conservative treatment of early endometrial cancer: preliminary results of a pilot study.
Laurelli G; Di Vagno G; Scaffa C; Losito S; Del Giudice M; Greggi S
Gynecol Oncol; 2011 Jan; 120(1):43-6. PubMed ID: 21040953
[TBL] [Abstract][Full Text] [Related]
31. [Pregnancy after conservative management of endometrial cancer].
Fuentes Dehesa M; Arteaga Gómez AC; Moreno Verduzco E; Aranda Flores CE
Ginecol Obstet Mex; 2009 Sep; 77(9):419-22. PubMed ID: 19899431
[TBL] [Abstract][Full Text] [Related]
32. Fertility-preserving treatment of stage IA, well-differentiated endometrial carcinoma in young women with hysteroscopic resection and high-dose progesterone therapy.
Yang HC; Liu JC; Liu FS
Taiwan J Obstet Gynecol; 2019 Jan; 58(1):90-93. PubMed ID: 30638488
[TBL] [Abstract][Full Text] [Related]
33. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
Yang YC; Wu CC; Chen CP; Chang CL; Wang KL
Gynecol Oncol; 2005 Nov; 99(2):287-93. PubMed ID: 16051341
[TBL] [Abstract][Full Text] [Related]
34. Gestational carrier pregnancy with oocytes obtained during surgery for stage IIIc ovarian cancer after controlled ovarian stimulation.
Zhang J; Grifo JA; Del Priore G
Fertil Steril; 2005 May; 83(5):1547-9. PubMed ID: 15866597
[TBL] [Abstract][Full Text] [Related]
35. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE
Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
[TBL] [Abstract][Full Text] [Related]
36. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome.
Kaku T; Yoshikawa H; Tsuda H; Sakamoto A; Fukunaga M; Kuwabara Y; Hataeg M; Kodama S; Kuzuya K; Sato S; Nishimura T; Hiura M; Nakano H; Iwasaka T; Miyazaki K; Kamura T
Cancer Lett; 2001 Jun; 167(1):39-48. PubMed ID: 11323097
[TBL] [Abstract][Full Text] [Related]
37. [Two cases of endometrial stromal sarcoma (ESS) in which survival was prolonged by administration of MPA].
Ishibashi M; Nakayama K; Shamima Y; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gan To Kagaku Ryoho; 2008 May; 35(5):857-61. PubMed ID: 18487930
[TBL] [Abstract][Full Text] [Related]
38. Endometrial cancer.
Arora V; Quinn MA
Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):311-24. PubMed ID: 22277287
[TBL] [Abstract][Full Text] [Related]
39. Endometrial adenocarcinoma in young patients: evaluation and fertility-preserving treatment.
Benshushan A
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):132-7. PubMed ID: 15541846
[TBL] [Abstract][Full Text] [Related]
40. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.
Ushijima K; Yahata H; Yoshikawa H; Konishi I; Yasugi T; Saito T; Nakanishi T; Sasaki H; Saji F; Iwasaka T; Hatae M; Kodama S; Saito T; Terakawa N; Yaegashi N; Hiura M; Sakamoto A; Tsuda H; Fukunaga M; Kamura T
J Clin Oncol; 2007 Jul; 25(19):2798-803. PubMed ID: 17602085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
